Ethics & Standards

Words by
Asimov Press
Subscribe to receive essays from Asimov Press.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Asimov Press is an editorially-independent publisher of digital magazines and books about biotechnology. We are funded by Asimov, a biotechnology company in Boston. Asimov, the company, has no control over anything published by Asimov Press. We do not publish pieces about Asimov or their commercial interests.

All pieces published by Asimov Press solely represent the opinions of their author. None of our articles claim complete objectivity, and none are necessarily representative of the views of our Editors, or of Asimov.

All of our articles are free to read. We do not publish sponsored content or use paywalls. Asimov Press aims to publish well-evidenced, narrative, contextual articles that will stand the test of time and be read many years after they were written.


Pieces published in our quarterly Issues are copy-edited and fact-checked. We issue corrections for factual errors. Corrections appear at the end of articles, and will clearly convey to readers what was wrong in the original article and how we have corrected it. Corrections include mistaken names and dates, or deeper errors. We do not make distinctions between corrections, clarifications, and editor’s notes. We do not issue corrections for spelling and punctuation errors.

Due to the uncertain nature of some of the topics covered in Asimov Press, it is not always possible to definitively verify facts. In some cases, authors must make a judgment based on a cited body of evidence, and should use appropriate language to express their degree of uncertainty. At times, readers will have opinions that differ from those of our authors, and we embrace the resulting discourse.

We do not tolerate plagiarism. Depending on the severity, we will correct or withdraw pieces with plagiarized elements.


Asimov Press articles strive to be fair and charitable. That means that they deal with the topics they discuss with reasonable epistemic standards, and fairly and accurately describe ideas that they disagree with. All articles should put biotechnology solutions in context, compare them to alternative ways to accomplish the same ends, and steelman the alternatives.


We do not currently have policies regarding the use of AI tools to supplement the research or writing process.

Learn More